CLNM Capital 📨 Genesis Mission, $2T Infrastructure, and Why Insurers Are Pulling Back

This week: Washington launches the Genesis Mission, a science initiative to improve scientific productivity, uniting national labs with tech giants. Meanwhile, the global data center boom continues reshaping the economy, straining power grids and raising sustainability fears. Europe eyes a different path forward through enterprise deployment. Plus, insurance companies are pulling back from covering AI liability risks.

The White House announced the Genesis Mission, comparing it in urgency and ambition to the Manhattan Project, to unite DOE's national laboratories, supercomputers, and AI systems into an integrated scientific platform. The initiative aims to transform research and speed up discoveries by using massive government scientific datasets targeting energy dominance, national security, and discovery science. Industry collaborators include AWS, Microsoft, NVIDIA, OpenAI, Anthropic, and Google. This program signals a major public funding pipeline for AI infrastructure and talent. 🔗 Read Trump’s Executive Order

Tech giants are pouring hundreds of billions into AI data centers — led by OpenAI’s $500B Stargate and Meta’s $72B 2025 capex — fueling a projected $2T revenue opportunity by 2032. But the boom is triggering acute power shortages, electricity price spikes up to 267%, and 3.5 Gigatons of added CO2 emissions this decade. As hyperscalers dominate, neocloud startups raise via $800B in private credit, minting 16 new billionaires while grids buckle and sustainability concerns grow urgent. 🔗 Bloomberg 🔗 Listen to the Reuters Viewsroom podcast discussion on tech debt relating to data centers.

Europe can leapfrog the US and China not thtough frontier models, but by leading in enterprise-scale AI deployment. The continent's strength lies in its vast, proprietary datasets across manufacturing, life sciences, and consumer goods, which are currently underutilized. Paired with trusted regulation, this offers a unique advantage. IBM data shows 66% of European executives already see productivity gains and centralized AI factories yield 34% higher returns. Success hinges on rapid upskilling and data-infrastructure investment. 🔗 Fortune

Amazon announced a massive investment of up to $50B to expand AI and supercomputing infrastructure for its US government customers. The multi-year plan will add nearly 1.3 gigawatts of compute capacity across AWS's secure GovCloud and Top Secret Regions, strengthening America's AI leadership. 🔗 CNBC

Nvidia's share price dropped 14% this month, erasing over $700B in value, due to fears of an AI bubble and competition, particularly from Alphabet’s processors. While analysts remain bullish (74 of 80 rate it 'Buy'), concern centers on whether Nvidia can maintain its market share against rivals like AMD and major customers developing in-house chips. 🔗 Bloomberg

This week's selection of early-stage opportunities highlights ventures harnessing specialized AI to disrupt multi-trillion dollar markets, focusing on solutions in life sciences infrastructure, healthtech, and career paths:

Our growth-stage picks focus on the massive infrastructural shifts currently reshaping the global economy, targeting critical solutions for manufacturing efficiency, energy grid stability, and advanced AI safety and reliability:

Ilya Sutskever discusses the "jaggedness" of current AI, citing the disconnect between high evaluations and inconsistent real-world performance, and how to ensure AGI goes well. He suggests the field is returning to an "age of research" to solve the fundamental problem of generalization and robust value functions. He also revealed that his startup Safe Superintelligence was raising at a $32B valuation and declined an acquisition offer from Meta. 🔗 Listen to the Interview on the Dwarkesh Podcast

Leading insurers including AIG, Great American, and WR Berkley are restricting or reconsidering coverage for AI-related claims, citing unpredictable and potentially multibillion-dollar liabilities from advanced systems like chatbots and autonomous agents. Facing challenges in risk modeling and regulatory uncertainty, carriers are seeking permission to cap exposure, forcing AI-adopting companies to confront rising self-insurance burdens and heightened operational risk in an underinsured environment. 🔗 Financial Times

AI offers the greatest immediate return by targeting the administrative overload (estimated at $1.2 trillion in the US), allowing clinicians to refocus on patient care. The goal is not to replace human connection, which is vital for patient well-being, but to give clinicians "superpowers" by using intelligent systems to automate paperwork, improve workflows, and deliver empathetic care. 🔗 Forbes

Google DeepMind's John Jumper, co-recipient of the Nobel Prize for AlphaFold 2, discusses the AI's impact five years on. AlphaFold has predicted over 200 million protein structures, greatly accelerating research in fields like protein design and drug discovery. While noting its current limitations, Jumper anticipates the next big step: fusing the AI's power with Large Language Models (LLMs) to advance scientific reasoning and problem-solving, stating he would be "shocked" if LLMs don't have a growing impact on science. 🔗 MIT Technology Review

📅 Dec 11, 2025 | ⏰ 09:00 to 19:00 CET (Brussels Time) | 🌐 Hybrid (In-person in Brussels and Available Virtually)

Full-day high-level discussion on the geopolitics of AI, Europe's evolving AI landscape, infrastructure for scalable and sustainable AI, and the business models shaping adoption. The event is co-located with the EIT AI Community. You can attend virtually free of charge. 🔗 Register

That’s it for this week.

Until next time,

The CLNM Capital

Want to share this newsletter with a friend? Use this link: https://clnm.beehiiv.com/